Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Davis, Brian R.; Hinds, Mark G.; Ting, Philip P. C., Australian Journal of Chemistry, 1992, vol. 45, # 5, p. 865 - 875
作者:Davis, Brian R.、Hinds, Mark G.、Ting, Philip P. C.
DOI:——
日期:——
Jullien, Bulletin de la Societe Chimique de France, 1936, vol. <5> 3, p. 1347,1350
作者:Jullien
DOI:——
日期:——
Anti-Viral Compounds
申请人:AbbVie Inc.
公开号:US20170157104A1
公开(公告)日:2017-06-08
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
[EN] MTORC1 MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE MTORC1 ET LEURS UTILISATIONS
申请人:AEOVIAN PHARMACEUTICALS INC
公开号:WO2021195599A1
公开(公告)日:2021-09-30
The disclosure provides compounds and salts that show high selectivity and inhibitory activity for mTORC1 and uses thereof for the treatment of disease.